- Filed
- Dec 9, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q3 2025 · Oct 31, 2024 | $773.63M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2024 | $1.06B |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $695.47M |
| Current Liabilities | Q3 2025 · Jan 31, 2024 | $711.69M |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $931.45M |
| Total Liabilities | Q3 2025 · Jan 31, 2024 | $938.64M |
| Current Assets | Q3 2025 · Oct 31, 2024 | $2.18B |
| Current Assets | Q3 2025 · Jan 31, 2024 | $2.58B |
| Total Assets | Q3 2025 · Oct 31, 2024 | $2.66B |
| Total Assets | Q3 2025 · Jan 31, 2024 | $2.95B |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 567.04M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 562.65M sh |
| Stock Repurchased | Q3 2025 · Oct 31, 2023 | $52.65M |
| Capex | Q3 2025 · Oct 31, 2023 | $3.56M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2023 | $153.48M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $1.96B |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $1.98B |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $1.96B |
| Stockholders Equity | Q3 2025 · Jan 31, 2023 | $1.92B |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | −$0.06 |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | −$0.22 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | −$0.06 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | −$0.22 |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $56.02M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $172.19M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $84.51M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $246.46M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$31.54M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$123.8M |
| Net Income | Q3 2025 · Jul 31, 2023 | −$60.36M |
| Net Income | Q3 2025 · Apr 30, 2023 | −$31.9M |
| Operating Income | Q3 2025 · Oct 31, 2023 | −$55.82M |
| Operating Income | Q3 2025 · Oct 31, 2023 | −$179.82M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $276M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $760.25M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2023 | $49.92M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2023 | $142.57M |
| Revenue | Q3 2025 · Oct 31, 2023 | $325.92M |
| Revenue | Q3 2025 · Oct 31, 2023 | $902.82M |